Driving Efficiency & Unlocking Scalability for PRAME Cell Therapy Manufacturing
- Anzu-cel is TCR T-cell therapy directed against PRAME, a target expressed in more than 50 cancers
- Scaling out efficiently: horizontal expansion to increase speed and throughput
- Preparing for commercial manufacturing through operational excellence